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dure.1 The appropriate interval between operations is hard to
define; LeMaire, Carter, and Coselli1 have advocated a 6-week
recovery period whereas Safi and colleagues4 recommend per-
forming the second-stage repair 4 weeks after the first stage. In
patients who have had elephant trunk repair of the arch, a second-
stage surgical approach via a left thoracotomy for the replacement
of the DTA is usually performed. On the other hand, several
groups have reported using endografts to complete the second
stage of the procedure.1,5 We chose endoluminal repair of the DTA
aneurysm because we believed that it reduced procedural time,
blood loss, length of intensive care unit stay, and hospital stay and
that it is associated with lower rates of morbidity and mortality if
compared with conventional open surgical procedures.
In our patient, the presence of an aneurysmal dilatation of
ARSA origin made management of this already complex patho-
logic condition even more complicated. Most patients with ARSA
are asymptomatic, but aneurysms in this location require surgical
treatment since they can cause serious complications: distal em-
bolization, rupture, and compression of neighboring structures.2,6
Because of the rareness of the ARSA aneurysms, surgical strate-
gies are still unclear. We have performed a bilateral subclavian-
carotid bypass after ETT to prepare the patient for the last step of
the procedure: stent grafting of the DTA. We have modified the
conventional 2-step repair of thoracic complex aneurysms adding
a third stage to suit the peculiar features of our patient. The 3-stage
approach has been effective and we believe that it can be safely
performed in patients with diffuse aneurysms of the thoracic aorta
involving an ARSA. Long-term evaluation in larger numbers of
patients is necessary to verify the efficacy of this technique.
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Systemic thrombolysis for prosthetic valve thrombosis in the immediate
postoperative period of major abdominal surgery
Manuel Ruiz-Bailén, MD, PhD,a,b Benjamín Narbona-Carvo, MD,c José Ángel Ramos-Cuadra, MD,d
Luis Rucabado-Aguilar, MD,a Carmen López-Caler, MD,e and Francisco Javier Gómez-Jiménez, MD,f Jaén, Almería, and
Granada, Spain
Thrombosis of a prosthetic valve is usually a cause foremergency cardiac surgery, particularly in the presenceof a major contraindication for systemic thrombolysis.Recent surgery is a major contraindication for the ad-
ministration of thrombolysis. Our objective is to describe the
administration of thrombolysis in a valve prosthesis after major
surgery.
Clinical Summary
A 61-year-old male patient was admitted for lower intestinal
obstruction. Sigmoidoscopy was performed and a tumor (moder-
ately differentiated adenocarcinoma) of the upper rectum, 12 cm
from the anal margin, was diagnosed. The patient had a metallic
cardiac valve prosthesis (St Jude Medical, Inc, St Paul, Minn) in
the mitral position and was being treated with acenocumarol. After
reversal of the anticoagulation, the patient underwent surgery, a
subtotal proctocolectomy with ileorectal anastomosis. The patient
was admitted to the intensive care unit (ICU) because of hemody-
namic instability in the first 24 hours, requiring high doses of
dopamine and norepinephrine, with an initial diagnosis of distrib-
utive shock. Forty-eight hours after the operation, a transesopha-
geal echocardiogram with hemodynamic assessment was per-
formed, revealing prosthetic valve thrombosis with obstruction and
abnormal disc motion of the medial hemidisc. A mean transmitral
pressure gradient of 19.6 mm Hg was observed (Figure 1). The
Doppler echocardiographic hemodynamic study was compatible
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with severe cardiogenic shock, with a left atrial pressure of 27 mm
Hg using the Kuecherer formula.1 The patient remained in hemo-
dynamically unstable condition, with acute pulmonary edema and
prerenal renal failure. Transfer to the reference hospital for surgery
in the reference cardiac surgery department was rejected. Because
of the persistence of cardiogenic shock, systemic thrombolysis
(100 mg of alteplase over 120 minutes) was administered on the
sixth postoperative day. A repeat transthoracic and transesopha-
geal echocardiogram, performed at the end of the alteplase infu-
sion, demonstrated disappearance of the prosthetic valve throm-
bosis and normalization of the transmitral gradient (Figure 2). The
patient’s hemodynamic situation normalized; extubation was pos-
sible 48 hours after administration of the alteplase, and the patient
was discharged from the ICU. A later complication occurred in the
form of an upper gastrointestinal hemorrhage resulting from an
acute, self-limiting lesion of the gastric mucosa, which did not
require blood transfusion. After transfer to the surgery ward, the
remainder of the postoperative course was within normal limits.
Follow-up at 6 months was normal.
Discussion
In the context of major abdominal surgery with a high risk of
hemorrhage and the long-term administration of anticoagulant
drugs, an option undertaken on occasion is the normalization of the
prothrombin activity for the duration of surgery, while simulta-
neously administering prophylactic doses of enoxaparin. However,
although the period the patient is without anticoagulation is rela-
tively short, in patients with a high risk of thrombosis, as in the
present case, in which the diagnosis was of adenocarcinoma, this
period may be sufficient for a thrombotic event, such as prosthetic
valve thrombosis, to develop.2
A further interesting problem in this discussion concerns reach-
ing the correct diagnosis; the most frequent diagnosis, distributive
shock resulting from cytokine release, was initially assumed. How-
ever, although the possibility of this situation existed, there was a
clear cardiologic cause in this patient: prosthetic valve thrombosis.
This case is a prime example of the benefit of echocardiography
carried out in the ICU, being performed to assess the hemody-
namic situation without suspecting the cardiologic cause a priori.
This might encourage intensive care physicians to consider the
need to use this technique routinely in hemodynamically unstable
patients, as it is a diagnostic technique that has proven very
effective and may change the therapeutic approach.3
Another problem consists in the therapeutic approach to be
followed after the diagnosis of prosthetic valve thrombosis has
been made in a patient in cardiogenic shock with multiorgan
dysfunction. Thrombolysis may have a hemorrhagic effect and
increase the emboligenic risk; however, it has been shown to be
effective and efficient in the treatment of prosthetic valve throm-
bosis and has been proposed as the initial treatment.4,5
In patients with a high hemorrhagic risk (an absolute contrain-
dication to systemic thrombolysis), as in the present case, the most
straightforward option would be surgery. Our patient also was not
a candidate for surgery, however, owing to an unacceptable sur-
gical risk. In this case, and in similar cases, systemic thrombolysis
may be administered as a final, desperate measure. Despite the
absolute contraindication for thrombolysis in the immediate post-
operative period, it has been administered at this time, and even
during surgery itself, in many cases, in case series of surgical
patients with pulmonary thromboembolism, and even in high-risk
situations such as pregnancy.6 For this reason, despite an absolute
contraindication for systemic thrombolysis, in specific cases such
as this one, the risk of its use should be evaluated and compared
with the natural course of the pathologic condition without its use.
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Figure 1. Mean transmitral gradient before the administration of
thrombolysis. MARC, 1.0 m/s.
Figure 2. Mean transmitral gradient after the administration of
thrombolysis. MARC, 1.0 m/s.
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Left atrial epithelioid hemangioendothelioma
Milan Lisy, MD,a Wolfram Beierlein, MD,a Hartmut Müller, MD, PhD,b Burkhard Bültmann, MD, PhD,b
and Gerhard Ziemer, MD, PhD,a Tubingen, Germany
Acase of cardiac epithelioid hemangioendothelioma ispresented, occurring as a clinically silent pediculatedleft atrial tumor in a 61-year-old male patient whounderwent pancreaticoduodenectomy for carcinoma
of the pancreas 3 years previously. The tumor was completely
resected with the presumptive clinical diagnosis of atrial myxoma.
Histologic and immunohistochemical investigations demonstrated
a mesenchymal tumor with antigen positivity for hemangioendo-
theliomas. Epithelioid hemangioendotheliomas are rare vascular
tumors of the heart, histologically characterized by capillary-sized
vessels lined by proliferating plump, often multilayered, epithelial-
like endothelial cells with cytoplasmic vacuoles.1 Similar to most
other primary intracardiac tumors, epithelioid hemangioendothe-
liomas may be found incidentally or after causing congestive heart
failure, pericardial effusions, outflow tract obstruction, or throm-
boembolic events. Because of the biologic behavior of epithelioid
hemangioendotheliomas, they are regarded as fully malignant,
rather than borderline neoplasms, and are to be resected radically
to prevent metastatic embolic disease.
Primary cardiac tumors are rare and most commonly histolog-
ically benign, with only 30% of them exhibiting histologic signs of
malignancy.2 Clinically, they may be found incidentally by chest
radiogram or by causing dysrhythmia, congestive heart failure,
pericardial effusions, outflow tract obstruction, or thromboembolic
events.3
The epithelioid hemangioendothelioma is histologically char-
acterized by capillary-sized vessels lined by proliferating plump
epithelial-like endothelial cells with cytoplasmic vacuoles, often
multilayered. It is regarded as a malignant, rather than a borderline,
neoplasm.
Clinical Summary
A 61-year-old man presented with nonspecific abdominal pain 3
years after he underwent a pancreaticoduodenectomy (Whipple’s
procedure) for adenocarcinoma of the pancreas. He had arterial
hypertension, noninsulin-dependent diabetes mellitus, and sleep-
induced apnea syndrome. His medication included metoprolol,
captopril, allopurinol, and pancreatic enzyme supplements. Spe-
cific tumor markers for the pancreas were normal (carcinoembry-
onic antigen 3 g/L, cancer antigen 19-9 5 kU/L). His electrocar-
diogram showed sinus rhythm and first-degree atrioventricular
block, without ST-T anomalies.
Computed tomography excluded intraabdominal masses and
remote lymphatic metastases of his previous pancreatic carcinoma.
The chest computed tomography scan showed a 3  3-cm non-
calcified mass on the posterolateral wall of the left atrium, a rather
atypical site for myxoma.
Transthoracic and transesophageal echocardiography demon-
strated good left ventricle function without hypertrophy and a
mobile pediculated left atrial mass displaying typical features of a
myxoma. The mitral valve was not involved.
Angiocardiography showed neither valvular nor coronary ab-
normalities, demonstrating the vascular supply of the atrial tumor
originating from the proximal circumflex coronary artery.
Elective surgery was performed through a midline sternotomy
using hypothermic cardiopulmonary bypass (30°C) and cold ante-
grade blood cardioplegic cardiac arrest. The left atrial tumor was
initially inspected through the right atrium and the persistent
foramen ovale. As described preoperatively, the tumor was pol-
ypoid, pediculated, and, atypically for a myxoma, located on the
left lateral atrial wall, far away from the interatrial septum. An
approach through the left atrial appendage was deemed to be better
suited for complete resection. After complete excision with an
adjacent strip of myocardium, the proximal left lower pulmonary
vein and its orifice had to be reconstructed with a patch of fresh
autologous pericardium. The patent foramen ovale was closed with
a direct suture.
The patient had an uneventful postoperative course and was
discharged on postoperative day 8.
The tumor was 4.2 cm in diameter and consisted exclusively of
epithelioid tumor cells in a myxoid matrix (Figure 1). The lesion
was encapsulated in a fibrotic sheath. The tumor was resected in
sano (R0). Immunohistochemically the tumor cells were negative
for myxoma markers: CK 5/6, PAN-CK, actin, CD34, CD68,
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